«OTHER TYPES» OF DIABETES: CONTRA-INSULAR HORMONES AND GENETIC PREDISPOSITION, NEW HORIZONS OF DIAGNOSTICS AND TREATMENT

Cover Page


Cite item

Full Text

Abstract

This article deals with various specific types of diabetes mellitus and other carbohydrate metabolism distortions occurring against the background of different endocrinopathies: hypercorticism, acromegaly, hyperparathyroidism, pheochromocytoma and other. Epidemiology of carbohydrate metabolism distortions as well as pathophysiological mechanisms of hyperglycemia development in various endocrinopathies are included in the article, the necessity of endocrinopathy screening among patients with refractory carbohydrate metabolism distortions is substantiated, objectives and tactics of glucose-reduction-therapy in these patients are defiend. This article also contains data upon prevalence and prevention of long-term complications of diabetes mellitus.

About the authors

G. A. Mel'nichenko

Sechenov First Moscow Medical University
Institute of clinical endocrinology Scientific Centre of Endocrinology Ministry of Healthcare and Social Development
of the Russian Federation, Moscow

Author for correspondence.
Email: teofrast2000@mail.ru
академик РАМН, директор института клинической эндокринологии ФГБУ ЭНЦ Минздравсоцразвития России, Москва Адрес: 117036, Москва, ул. Дмитрия Ульянова, 11 Тел.: (495)500-00-96 Russian Federation

I. V. Glinkina

Sechenov First Moscow Medical University

Email: irina_glinkina@rambler.ru
кандидат медицинских наук, ассистент кафедры эндокринологии ГБОУ ВПО Первый Московский государственный медицинский университет им. И.М. Сеченова Минздравсоцразвития России Адрес: 119991, Москва, ул. Трубецкая, 8, стр. 2 Russian Federation

D. M. Surovtseva

Sechenov First Moscow Medical University

Email: dmsurovtseva@mail.ru
аспирант кафедры эндокринологии ГБОУ ВПО Первый Московский государственный медицинский университет им. И.М. Сеченова Минздравсоцразвития России Адрес: 119991, Москва, ул. Трубецкая, 8, стр. 2 Тел.: (499)248-38-67 Russian Federation

References

  1. IDF Diabetes Atlas, 5th edition. Available at: http:// www.idf.org
  2. Katznelson L., Atkinson J.L., Cook D.M. et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly-2011 update. Endocr. Pract. 2011; 17 (Suppl. 4): 1–44.
  3. Steffensen C., Bak A.M., Rubeck K.Z. et al. Epidemiology of Cushing’s syndrome. Neuroendocrinology. 2010; 92 (Suppl. 1): 1–5. [Epub 2010 Sep 10].
  4. Kronenberg H.M., Melmed S., Polonsky K.S., Larsen P.R. Williams textbook of endocrinology. 11th edition. Elsevier Health Sciences. 2008.
  5. Rostomyan L.G., Rojinskaya L.Ya., Mokrysheva N.G. et al. Lechaschii vrach = Practicing doctor. 2010; 11: 25–28.
  6. Dedov I.I., Bel'cevich D.G., Kuznecov N.S., Mel'nichenko G.A. Feohromocitoma [Pheochromocytoma]. Moscow, Prakticheskaya medicina, 2005.
  7. Schirpenbach C., Segmiller F., Diederich S. et al. The Diagnosis and Treatment of Primary Hyperaldosteronism in Germany. Results on 555 Patients From the German Conn Registry. Dtsch. Arztebl. Int. 2009; 106: 305–311.
  8. Catargi B., Rigalleau V., Poussin A. et al. Occult Cushing’s syndrome in type-2 diabetes. J. Clin. Endocrinol. Metab. 2003; 88 (12): 5808–13.
  9. Rosario P.W. Frequency of acromegaly in adults with diabetes or glucose intolerance and estimated prevalence in the general population. Pituitary. 2011; 14 (3): 217–221.
  10. Resmini E., Minuto F., Colao A., Ferone D. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities. Acta Diabetol. 2009; 46 (2): 85–95. [Epub 2009 Mar 26].
  11. Resmini E., Minuto F., Colao A., Ferone D. The European Registry on Cushing’s syndrome: 2-year experience. Baseline demographic and clinical characteristics. ERCUSYN Study Group. Eur. J. Endocrinol. 2011; 165 (3): 383–92. [Epub 2011 Jun 29].
  12. Reincke M., Meisinger C., Holle R. et al. Is primary aldosteronism associated with diabetes mellitus. Results of the German Conn’s Registry. Participants of the German Conn’s Registry. Horm. Metab. Res. 2010; 42 (6): 435–9. [Epub 2010 Jan 29].
  13. Matrozova J., Steichen O., Amar L. et al. Fasting plasma glucose and serum lipids in patients with primary aldosteronism: a controlled cross-sectional study. Hypertension. 2009; 53 (4): 605–10. [Epub 2009 Feb 16].
  14. Taylor W.H., Khaleeli A.A. Prevalence of primary hyperparathyroidism in patients with diabetes mellitus. Diabetic Medicine. 1997; 14: 386–389.
  15. Mоller N., Jоrgensen J.O. Effects of growth hormone on glucose, lipid and protein metabolism in human subjects. Endocr. Rev. 2009; 30 (2): 152–77. [Epub 2009 Feb 24].
  16. Trementino L., Appolloni G., Concettoni C. et al. Association of glucocorticoid receptor polymorphism A3669G with decreased risk of developing diabetes in patients with Cushing’s syndrome. 2012; 166 (1): 35–42. [Epub 2011 Nov 2].
  17. Pivonello R., De Martino M.C., De Leo M. et al. Cushing’s syndrome: aftermath of the cure. Arq. Bras. Endocrinol. Metabol. 2007; 51 (8): 1381–91.
  18. Tzanela M., Vassiliadi D.A., Gavalas N. et al. Glucose homeostasis in patients with acromegaly treated with surgery or somatostatin analogues. Clin Endocrinol. 2011 Feb 2. doi: 10.1111/j.1365-2265.2011.03996.x. [Epub ahead of print].
  19. Belaya Zh.E., Il'in A.V., Mel'nichenko G.A. et al. Ozhirenie i metabolism = Obesity and metabolism. 2011; 2 (27): 56–64.
  20. Rosario P.W., Calsolari M.R. Screening for acromegaly by application of a simple questionnaire evaluating the enlargement of extremities in adult patients seen at primary health care units. Pituitary. 2011 Mar 8. [Epub ahead of print].
  21. Cassar J., Kohner E.M., Joplin G.F. Diabetic retinopathy in Cushing’s disease. Postgrad. Med. J. 1981; 57 (672): 645–6.
  22. Plotz C.M., Knowlton A.I., Ragan C. The natural history of Cushing’s syndrome. Am. J. Med. 1952; 13 (5): 597–614.
  23. Cambuli V.M., Galdiero M., Mastinu M. et al. Glycometabolic control in Acromegalic patients with Diabetes: a study of the effects of different treatments for GH excess and for hyperglycaemia. J. Endocrinol. Invest. 2011 Apr 28. [Epub ahead of print].
  24. Standards of Medical Care in Diabetes. American Diabetes Association. 2008.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2012 "Paediatrician" Publishers LLC



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies